{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:33:46Z","timestamp":1792503226277,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007408","name":"Medical Center, University of Pittsburgh","doi-asserted-by":"publisher","award":["P30CA047904"],"award-info":[{"award-number":["P30CA047904"]}],"id":[{"id":"10.13039\/100007408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015166","name":"UPMC Enterprises","doi-asserted-by":"publisher","award":["P50CA272218-01A1"],"award-info":[{"award-number":["P50CA272218-01A1"]}],"id":[{"id":"10.13039\/100015166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD028483"],"award-info":[{"award-number":["S10OD028483"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["2T32CA082084-16A1"],"award-info":[{"award-number":["2T32CA082084-16A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001368","name":"V Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ccell.2024.09.007","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T10:41:30Z","timestamp":1728556890000},"page":"1864-1881.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"],"prefix":"10.1016","volume":"42","author":[{"given":"Ian P.","family":"MacFawn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Magnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Gorecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl","family":"Kunning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufiaat","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medard Ernest","family":"Kaiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda","family":"Atiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayana T.","family":"Ruffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Rinda","family":"Soong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riyue","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan G.","family":"Coffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tullia C.","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2024.09.007_bib1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Bell","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.09.007_bib2","series-title":"SEER Cancer Statistics Review, 1975-2016","article-title":"SEER Cancer Statistics Review","author":"Howlader","year":"2018"},{"key":"10.1016\/j.ccell.2024.09.007_bib3","doi-asserted-by":"crossref","first-page":"viii57","DOI":"10.1093\/annonc\/mdx442","article-title":"New treatments in ovarian cancer","volume":"28","author":"Pujade-Lauraine","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ccell.2024.09.007_bib4","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1200\/JCO.2016.34.15_suppl.5533","article-title":"Avelumab (MSB0010718C; anti-PD-L1) in patients with recurrent\/refractory ovarian cancer from the JAVELIN Solid Tumor phase Ib trial: Safety and clinical activity","volume":"34","author":"Disis","year":"2016","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2024.09.007_bib5","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1200\/JCO.2015.62.3397","article-title":"Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer","volume":"33","author":"Hamanishi","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2024.09.007_bib6","doi-asserted-by":"crossref","first-page":"vi300","DOI":"10.1093\/annonc\/mdw374.18","article-title":"Safety, clinical activity and biomarkers of atezolizumab (atezo) in advanced ovarian cancer (OC)","volume":"27","author":"Infante","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ccell.2024.09.007_bib7","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1200\/jco.2015.33.15_suppl.5510","article-title":"Antitumor activity and safety of pembrolizumab in patients (pts) with PD-L1 positive advanced ovarian cancer: Interim results from a phase Ib study","volume":"33","author":"Varga","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2024.09.007_bib8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ygyno.2011.09.039","article-title":"Prognostic significance of tumor-infiltrating T\u00a0cells in ovarian cancer: a meta-analysis","volume":"124","author":"Hwang","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ccell.2024.09.007_bib9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T\u00a0cells, recurrence, and survival in epithelial ovarian cancer","volume":"348","author":"Zhang","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2024.09.007_bib10","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1158\/1078-0432.CCR-12-0234","article-title":"CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T\u00a0cells promote favorable prognosis in ovarian cancer","volume":"18","author":"Nielsen","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2024.09.007_bib11","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1158\/1078-0432.CCR-15-2762","article-title":"Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer","volume":"22","author":"Kroeger","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2024.09.007_bib12","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1158\/1078-0432.CCR-12-0234","article-title":"CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27\u2212 Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer","volume":"18","author":"Nielsen","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2024.09.007_bib13","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1038\/s41467-021-23355-x","article-title":"B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma","volume":"12","author":"Ruffin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2024.09.007_bib14","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/ni.3290","article-title":"Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma","volume":"16","author":"Finkin","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2024.09.007_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jhep.2018.09.003","article-title":"Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma","volume":"70","author":"Calderaro","year":"2019","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ccell.2024.09.007_bib16","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1900635","article-title":"Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer","volume":"10","author":"J Gunderson","year":"2021","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ccell.2024.09.007_bib17","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41586-022-05496-1","article-title":"Ovarian cancer mutational processes drive site-specific immune evasion","volume":"612","author":"Vazquez-Garcia","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.09.007_bib18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1006\/gyno.1998.5275","article-title":"The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes?","volume":"72","author":"Dubeau","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ccell.2024.09.007_bib19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ccell.2024.09.007_bib20","article-title":"Ovarian cancer pathogenesis: a model in evolution","volume":"2010","author":"Karst","year":"2010","journal-title":"J.\u00a0Oncol."},{"key":"10.1016\/j.ccell.2024.09.007_bib21","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2024.09.007_bib22","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1038\/s41467-019-13116-2","article-title":"Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2024.09.007_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ccell.2024.09.007_bib24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Sautes-Fridman","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2024.09.007_bib25","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ni1100","article-title":"Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5","volume":"5","author":"Allen","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2024.09.007_bib26","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1084\/jem.20181216","article-title":"Type I interferon induces CXCL13 to support ectopic germinal center formation","volume":"216","author":"Denton","year":"2019","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2024.09.007_bib27","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1073\/pnas.1520112113","article-title":"CXCL13 is a plasma biomarker of germinal center activity","volume":"113","author":"Havenar-Daughton","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2024.09.007_bib28","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.3389\/fimmu.2018.02469","article-title":"Regulation of the Germinal Center Response","volume":"9","author":"Stebegg","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ccell.2024.09.007_bib29","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.immuni.2018.04.006","article-title":"Single-Cell RNA Sequencing of Lymph Node Stromal Cells Reveals Niche-Associated Heterogeneity","volume":"48","author":"Rodda","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2024.09.007_bib30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1146\/annurev-immunol-032713-120252","article-title":"Stromal cells in chronic inflammation and tertiary lymphoid organ formation","volume":"33","author":"Buckley","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ccell.2024.09.007_bib31","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.4049\/jimmunol.0803974","article-title":"Inflammation recapitulates the ontogeny of lymphoid stromal cells","volume":"182","author":"Peduto","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2024.09.007_bib32","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cell.2012.05.032","article-title":"Follicular dendritic cells emerge from ubiquitous perivascular precursors","volume":"150","author":"Krautler","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2024.09.007_bib33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3389\/fimmu.2016.00477","article-title":"Stromal Fibroblasts in Tertiary Lymphoid Structures: A Novel Target in Chronic Inflammation","volume":"7","author":"Barone","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ccell.2024.09.007_bib34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cyto.2012.04.016","article-title":"Tonsil-derived mesenchymal progenitor cells acquire a follicular dendritic cell phenotype under cytokine stimulation","volume":"59","author":"Cho","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.ccell.2024.09.007_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-3-030-37184-5_3","article-title":"Mesenchymal Stem Cells in the Tumor Microenvironment","volume":"1234","author":"Atiya","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ccell.2024.09.007_bib36","doi-asserted-by":"crossref","DOI":"10.3791\/62382","article-title":"An Orthotopic Mouse Model of Ovarian Cancer using Human Stroma to Promote Metastasis","author":"Atiya","year":"2021","journal-title":"J Vis Exp"},{"key":"10.1016\/j.ccell.2024.09.007_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi5790","article-title":"Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition","volume":"7","author":"Cascio","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ccell.2024.09.007_bib38","series-title":"Ovarian Carcinoma-Associated Mesenchymal Stem Cells Arise from Tissue-Specific Normal Stroma","author":"Coffman","year":"2019"},{"key":"10.1016\/j.ccell.2024.09.007_bib39","article-title":"Epigenetic reprogramming towards mesenchymal-epithelial transition in ovarian cancer-associated mesenchymal stem cells drives metastasis","author":"Fan","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.ccell.2024.09.007_bib40","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.18632\/oncotarget.6870","article-title":"Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4\/HH signaling loop","volume":"7","author":"Coffman","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ccell.2024.09.007_bib41","article-title":"Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer","volume":"5","author":"Brown","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ccell.2024.09.007_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108473","article-title":"Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis","volume":"33","author":"Fan","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2024.09.007_bib43","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1158\/1078-0432.CCR-18-1481","article-title":"Prognostic Significance of Tumor-Infiltrating B Cells and Plasma Cells in Human Cancer","volume":"24","author":"Wouters","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2024.09.007_bib44","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41586-020-03144-0","article-title":"IgA transcytosis and antigen recognition govern ovarian cancer immunity","volume":"591","author":"Biswas","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.09.007_bib45","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1007\/s43032-023-01188-x","article-title":"Tertiary Lymphoid Structures Are Associated with a Favorable Prognosis in High-Grade Serous Ovarian Cancer Patients","volume":"30","author":"Zhang","year":"2023","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.ccell.2024.09.007_bib46","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s11357-023-00742-4","article-title":"Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer","volume":"45","author":"Gyorffy","year":"2023","journal-title":"Geroscience"},{"key":"10.1016\/j.ccell.2024.09.007_bib47","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1038\/s41598-021-84787-5","article-title":"Pancancer survival analysis of cancer hallmark genes","volume":"11","author":"Nagy","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ccell.2024.09.007_bib48","first-page":"517","article-title":"Prognostically relevant gene signatures of high-grade serous ovarian carcinoma","volume":"123","author":"Verhaak","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ccell.2024.09.007_bib49","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1158\/0008-5472.CAN-17-1987","article-title":"Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma","volume":"78","author":"Silina","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2024.09.007_bib50","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00262-021-03093-1","article-title":"Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer","volume":"71","author":"Qin","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ccell.2024.09.007_bib51","article-title":"Peritumoral Tertiary Lymphoid Structures Correlate With Protective Immunity and Improved Prognosis in Patients With Hepatocellular Carcinoma","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ccell.2024.09.007_bib52","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1378844","article-title":"Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer","volume":"7","author":"Posch","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ccell.2024.09.007_bib53","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.immuni.2004.09.006","article-title":"Induction of secondary and tertiary lymphoid structures in the skin","volume":"21","author":"Cupedo","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2024.09.007_bib54","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/s41416-022-02122-9","article-title":"Prognostic relevance of HRDness gene expression signature in ovarian high-grade serous carcinoma; JGOG3025-TR2 study","volume":"128","author":"Takamatsu","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccell.2024.09.007_bib55","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ccell.2024.09.007_bib56","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","article-title":"The three Es of cancer immunoediting","volume":"22","author":"Dunn","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ccell.2024.09.007_bib57","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2024.09.007_bib58","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.molimm.2018.11.006","article-title":"Grainyhead-like-2 confers NK-sensitivity through interactions with epigenetic modifiers","volume":"105","author":"MacFawn","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ccell.2024.09.007_bib59","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1271858","article-title":"Acquisition of tumor cell phenotypic diversity along the EMT spectrum under hypoxic pressure: Consequences on susceptibility to cell-mediated cytotoxicity","volume":"6","author":"Terry","year":"2017","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ccell.2024.09.007_bib60","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/1878-0261.12093","article-title":"New insights into the role of EMT in tumor immune escape","volume":"11","author":"Terry","year":"2017","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ccell.2024.09.007_bib61","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1158\/0008-5472.CAN-12-2432","article-title":"Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis","volume":"73","author":"Akalay","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2024.09.007_bib62","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/s41591-018-0057-z","article-title":"A transcriptionally and functionally distinct PD-1(+) CD8(+) T\u00a0cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade","volume":"24","author":"Thommen","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2024.09.007_bib63","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1038\/s41467-024-46873-w","article-title":"Tertiary lymphoid structures and B cells determine clinically relevant T\u00a0cell phenotypes in ovarian cancer","volume":"15","author":"Kasikova","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2024.09.007_bib64","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1186\/s12885-020-07274-6","article-title":"TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells","volume":"20","author":"Escalona","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ccell.2024.09.007_bib65","doi-asserted-by":"crossref","first-page":"6907","DOI":"10.1002\/jcp.30350","article-title":"Overexpressed COL5A1 is correlated with tumor progression, paclitaxel resistance, and tumor-infiltrating immune cells in ovarian cancer","volume":"236","author":"Zhang","year":"2021","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.ccell.2024.09.007_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14092298","article-title":"Shifting the Soil: Metformin Treatment Decreases the Protumorigenic Tumor Microenvironment in Epithelial Ovarian Cancer","volume":"14","author":"Taylor","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ccell.2024.09.007_bib70","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ccr.2009.10.018","article-title":"A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2","volume":"16","author":"Mok","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2024.09.007_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ccell.2024.09.007_bib69","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2024.09.007_bib68","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610824003556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610824003556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:57:38Z","timestamp":1762959458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610824003556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":70,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1535610824003556"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2024.09.007","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2024.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}